
DNA vs IMCR
$DNA vs $IMCR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs IMCR: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: DNA +7.8% and IMCR -27.7%, against the S&P 500 at +10.6%.
- ·DNA has support 0.1% below at $8.40; IMCR has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DNA vs IMCR: the quick read
- ·IMCR is the larger company by market cap ($1.44B vs $560M).
- ·DNA has been more active on our scanner (197 vs 70 alerts in 30 days).
- ·IMCR has the smaller float (47.3M vs 65.6M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 197 and 70 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Watching DNA or IMCR? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and IMCR on TheDesperateTrader.
- Is DNA or IMCR the better stock?
- "Better" depends on your goal, and these two are not alike. IMCR is the larger company by market cap ($1.44B vs $560M). DNA has been more active on our scanner (197 vs 70 alerts in 30 days). IMCR has the smaller float (47.3M vs 65.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and IMCR?
- The differences that matter: they are similar in size ($560M vs $1.44B); they trade at very different share prices ($8.41 vs $27.51); DNA sits at 24% of its 52-week range against 1% for IMCR; our scanner flagged DNA 197 times in the last 30 days against 70 for IMCR. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and IMCR is more active right now?
- Right now DNA is at about 0.8x its normal volume and IMCR is at about 0.8x, so IMCR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DNA or IMCR in the stronger trend?
- DNA is below its 50-day average of $10.38 and below its 200-day average of $8.63; IMCR is below its 50-day average of $30.63 and below its 200-day average of $31.51. DNA leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or IMCR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and IMCR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.